New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - potassium chloride 0.15%{relative}; sodium chloride 0.9%{relative} - solution for infusion - active: potassium chloride 0.15%{relative} sodium chloride 0.9%{relative} excipient: water for injection - indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - potassium chloride 0.224%; sodium chloride 0.9% - solution for infusion - 30 mmol/l - active: potassium chloride 0.224% sodium chloride 0.9% - indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - sodium chloride 9 mg/ml - solution for injection - 0.9% w/v - active: sodium chloride 9 mg/ml excipient: water for injection

Ireland - English - HPRA (Health Products Regulatory Authority)

maco pharma (uk) ltd - sodium chloride - solution for infusion - 0.9 %w/v - electrolytes

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - potassium chloride 29.8 g/l; sodium chloride 9 g/l;   - solution for infusion - active: potassium chloride 29.8 g/l sodium chloride 9 g/l   excipient: hydrochloric acid water for injection - indicated as a source of water and to restore electrolyte balance as required by the patient's clinical conditon, such as hypokalaemia.

United States - English - NLM (National Library of Medicine)

hospira, inc. - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0 - potassium chloride 1.79 g in 1000 ml - these solutions are indicated in patients requiring parenteral administration of potassium chloride and the replacement of extracellular losses of fluids and electrolytes with minimal carbohydrate calories. solutions containing potassium chloride are contraindicated in diseases where high potassium levels may be encountered. solutions containing lactate are not for use in the treatment of lactic acidosis. to open tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication - prepare additive port. prepare additive port. - using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw need

United States - English - NLM (National Library of Medicine)

hospira, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0 - sodium chloride 600 mg in 100 ml - these solutions are indicated for parenteral replacement of extracellular losses of fluid and electrolytes, with or without minimal carbohydrate calories, as required by the clinical condition of the patient. solutions containing lactate are not for use in the treatment of lactic acidosis. to open:   tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication   - prepare additive port. - using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. - the additive port may be protected by covering with an additive cap. - mix container contents thoroughly.

United States - English - NLM (National Library of Medicine)

hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - dextrose monohydrate 5 g in 100 ml - intravenous solutions containing dextrose and sodium chloride are indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical condition of the patient. none known. to open: tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. to add medication - prepare additive port. - using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. - the additive port may be protected by covering with an additive cap. - mix container contents thoroughly. preparation for administration (use aseptic technique) - close flow control clamp of administration set. - remove cover from outlet port at bottom of container. - insert piercing pin of administration set into port with a twisting motion until the set is firmly seated.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharmaceuticals ltd - sodium chloride - solution for injection - 9mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharmaceuticals ltd - sodium chloride - solution for injection - 9mg/1ml